Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Notes Payables (2016 - 2017)

Sanara MedTech's Notes Payables history spans 7 years, with the latest figure at $1.2 million for Q4 2017.

  • For Q4 2017, Notes Payables changed N/A year-over-year to $1.2 million; the TTM value through Dec 2017 reached $1.2 million, changed N/A, while the annual FY2017 figure was $1.2 million, N/A changed from the prior year.
  • Notes Payables reached $1.2 million in Q4 2017 per SMTI's latest filing, roughly flat from $1.2 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $2.2 million in Q1 2013 to a low of $223500.0 in Q2 2017.
  • Average Notes Payables over 4 years is $813461.2, with a median of $443800.0 recorded in 2015.
  • Peak YoY movement for Notes Payables: soared 3388.79% in 2013, then plummeted 49.54% in 2017.
  • A 4-year view of Notes Payables shows it stood at $415620.0 in 2013, then rose by 7.0% to $444700.0 in 2015, then dropped by 0.4% to $442900.0 in 2016, then surged by 170.94% to $1.2 million in 2017.
  • Per Business Quant, the three most recent readings for SMTI's Notes Payables are $1.2 million (Q4 2017), $1.2 million (Q3 2017), and $223500.0 (Q2 2017).